Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 2
2008 8
2009 6
2010 10
2011 6
2012 7
2013 5
2014 5
2015 5
2016 2
2017 2
2018 5
2019 6
2020 9
2021 5
2022 5
2023 7
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

85 results

Results by year

Filters applied: . Clear all
Page 1
Did you mean alessandro musella (245 results)?
Low-contrast visual acuity test is associated with central inflammation and predicts disability development in newly diagnosed multiple sclerosis patients.
Dolcetti E, Buttari F, Bruno A, Azzolini F, Gilio L, Di Caprio V, Lauritano G, Borrelli A, Galifi G, Furlan R, Finardi A, Musella A, Guadalupi L, Mandolesi G, Rovella V, Centonze D, Stampanoni Bassi M. Dolcetti E, et al. Among authors: musella a. Front Neurol. 2024 Feb 23;15:1326506. doi: 10.3389/fneur.2024.1326506. eCollection 2024. Front Neurol. 2024. PMID: 38585351 Free PMC article.
Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis.
Guadalupi L, Mandolesi G, Vanni V, Balletta S, Caioli S, Pavlovic A, De Vito F, Fresegna D, Sanna K, Vitiello L, Nencini M, Tartacca A, Mariani F, Rovella V, Schippling S, Ruf I, Collin L, Centonze D, Musella A. Guadalupi L, et al. Among authors: musella a. Neuropharmacology. 2024 Apr 2;252:109940. doi: 10.1016/j.neuropharm.2024.109940. Online ahead of print. Neuropharmacology. 2024. PMID: 38570068 Free article.
Mood disturbances in newly diagnosed Parkinson's Disease patients reflect intrathecal inflammation.
Stampanoni Bassi M, Gilio L, Galifi G, Buttari F, Dolcetti E, Bruno A, Belli L, Modugno N, Furlan R, Finardi A, Mandolesi G, Musella A, Centonze D, Olivola E. Stampanoni Bassi M, et al. Among authors: musella a. Parkinsonism Relat Disord. 2024 Feb 28;122:106071. doi: 10.1016/j.parkreldis.2024.106071. Online ahead of print. Parkinsonism Relat Disord. 2024. PMID: 38432021 Free article.
Preventive exercise and physical rehabilitation promote long-term potentiation-like plasticity expression in patients with multiple sclerosis.
Stampanoni Bassi M, Gilio L, Buttari F, Dolcetti E, Bruno A, Galifi G, Azzolini F, Borrelli A, Mandolesi G, Gentile A, De Vito F, Musella A, Simonelli I, Centonze D, Iezzi E. Stampanoni Bassi M, et al. Among authors: musella a. Eur J Neurol. 2024 Mar;31(3):e16071. doi: 10.1111/ene.16071. Epub 2023 Sep 27. Eur J Neurol. 2024. PMID: 37754770
Distinct intrathecal inflammatory signatures following relapse and anti-COVID-19 mRNA vaccination in multiple sclerosis.
Bruno A, Buttari F, Dolcetti E, Azzolini F, Borrelli A, Lauritano G, Di Caprio V, Rizzo FR, Gilio L, Galifi G, Furlan R, Finardi A, Guadalupi L, Musella A, Mandolesi G, Centonze D, Stampanoni Bassi M. Bruno A, et al. Among authors: musella a. Mult Scler. 2023 Oct;29(11-12):1383-1392. doi: 10.1177/13524585231197928. Epub 2023 Sep 12. Mult Scler. 2023. PMID: 37698019
MiR-142-3p is a Critical Modulator of TNF-mediated Neuronal Toxicity in Multiple Sclerosis.
De Vito F, Balletta S, Caioli S, Musella A, Guadalupi L, Vanni V, Fresegna D, Bassi MS, Gilio L, Sanna K, Gentile A, Bruno A, Dolcetti E, Buttari F, Pavone L, Furlan R, Finardi A, Perlas E, Hornstein E, Centonze D, Mandolesi G. De Vito F, et al. Among authors: musella a. Curr Neuropharmacol. 2023;21(12):2567-2582. doi: 10.2174/1570159X21666230404103914. Curr Neuropharmacol. 2023. PMID: 37021418 Free PMC article.
Genetic regulation of IL-8 influences disease presentation of multiple sclerosis.
Dolcetti E, Bruno A, Azzolini F, Gilio L, Pavone L, Iezzi E, Galifi G, Gambardella S, Ferese R, Buttari F, De Vito F, Colantuono P, Furlan R, Finardi A, Musella A, Mandolesi G, Centonze D, Stampanoni Bassi M. Dolcetti E, et al. Among authors: musella a. Mult Scler. 2023 Apr;29(4-5):512-520. doi: 10.1177/13524585231155049. Epub 2023 Feb 19. Mult Scler. 2023. PMID: 36803228
BACE1 influences clinical manifestations and central inflammation in relapsing remitting multiple sclerosis.
Bruno A, Dolcetti E, Azzolini F, Buttari F, Gilio L, Iezzi E, Galifi G, Borrelli A, Furlan R, Finardi A, Carbone F, De Vito F, Musella A, Guadalupi L, Mandolesi G, Matarese G, Centonze D, Stampanoni Bassi M. Bruno A, et al. Among authors: musella a. Mult Scler Relat Disord. 2023 Mar;71:104528. doi: 10.1016/j.msard.2023.104528. Epub 2023 Jan 24. Mult Scler Relat Disord. 2023. PMID: 36709576 Free article.
85 results